Sysmex America is lighting the way to better health with diagnostic solutions that transform the future of healthcare and contribute to healthier lives. Its innovative hematology, urinalysis and flow cytometry testing technology is reshaping the world of diagnostics across the U.S., Canada and Latin America. We expand the boundaries of diagnostic science, while developing tools and systems to help our customers respond to increasing demands and diminishing resources. Sysmex was the first company to: Market an immature granulocyte count, Bring the diode laser to hematology, Use fluorescent flow cytometry for more accurate and sensitive counting of nucleated red blood cells.